Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ameneh Shokati

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Oncology (Northwood, London, England)|September 27, 2025
Engineering adoptive cell therapy for solid tumorsMaryam Sanjary, Ameneh Shokati, Mahshid Akhavan Rahnama, et al.
Reviews in Medical Virology|January 29, 2024
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID-19 infectionYousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Cancer Cell International|July 21, 2025
Revolutionizing cancer treatment: engineering mesenchymal stem cell-derived small extracellular vesiclesAmeneh Shokati, Mahshid Akhavan Rahnama, Ladan Jalali, et al.
Frontiers in Immunology|June 27, 2025
Allogeneic CART progress: platforms, current progress and limitationsAmeneh Shokati, Maryam Sanjari-Pour, Mahshid Akhavan Rahnama, et al.
Cytokine|June 15, 2023
The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effectYousef Rasmi, Ladan Jalali, Saliha Khalid, et al.
Stem Cell Research & Therapy|July 14, 2021
A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosisAmeneh Shokati, Abdorreza Naser Moghadasi, Mohsen Nikbakht, et al.
Molecular Biology Reports|June 4, 2026
Harnessing CAR-NK cells against multiple myeloma: current landscape and future directionsSamira Anvari, Jalal Naghinezhad, Ameneh Shokati, et al.
Acta Histochemica|June 6, 2022
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infectionYousef Rasmi, Shima Hatamkhani, Roya Naderi, et al.
IBRO Neuroscience Reports|January 2, 2023
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disordersYousef Rasmi, Ameneh Shokati, Amber Hassan, et al.
Molecular Biology Reports|March 29, 2024
Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosisAmeneh Shokati, Abdorreza Naser Moghadasi, Andisheh Ghashghaei, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|September 27, 2025
Engineering adoptive cell therapy for solid tumorsMaryam Sanjary, Ameneh Shokati, Mahshid Akhavan Rahnama, et al.
Reviews in Medical Virology|January 29, 2024
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID-19 infectionYousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Cancer Cell International|July 21, 2025
Revolutionizing cancer treatment: engineering mesenchymal stem cell-derived small extracellular vesiclesAmeneh Shokati, Mahshid Akhavan Rahnama, Ladan Jalali, et al.
Frontiers in Immunology|June 27, 2025
Allogeneic CART progress: platforms, current progress and limitationsAmeneh Shokati, Maryam Sanjari-Pour, Mahshid Akhavan Rahnama, et al.
Cytokine|June 15, 2023
The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effectYousef Rasmi, Ladan Jalali, Saliha Khalid, et al.
Stem Cell Research & Therapy|July 14, 2021
A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosisAmeneh Shokati, Abdorreza Naser Moghadasi, Mohsen Nikbakht, et al.
Molecular Biology Reports|June 4, 2026
Harnessing CAR-NK cells against multiple myeloma: current landscape and future directionsSamira Anvari, Jalal Naghinezhad, Ameneh Shokati, et al.
Acta Histochemica|June 6, 2022
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infectionYousef Rasmi, Shima Hatamkhani, Roya Naderi, et al.
IBRO Neuroscience Reports|January 2, 2023
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disordersYousef Rasmi, Ameneh Shokati, Amber Hassan, et al.
Molecular Biology Reports|March 29, 2024
Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosisAmeneh Shokati, Abdorreza Naser Moghadasi, Andisheh Ghashghaei, et al.
Pageof 2